Healio Gastroenterology


The following articles appeared in the print edition of HEALIO GASTROENTEROLOGY.

Table of Contents
By the Numbers

10 Top Things an IBD Nurse Should Know

Cover Story

Evidence of PPI Risks Weak, But Overuse Remains a Problem

Drug/Device Pipeline

Tenapanor Shows Better Results in Second Pivotal IBS-C Trial

FDA Approves HBV Vaccine Heplisav-B for Adults

FDA Clears Minimally Invasive, Robotically-assisted Surgical Device

New Colonoscopy Dye Product Receives PDUFA Date

At-home Gluten Test Launched in US, Canada

Celgene Halts Mongersen Trials in Crohn’s Disease

FDA Clears New Test to Aid in Identifying Hereditary Colon Cancer


PPI Risk-Benefits: A Practical Approach to Patient Discussions

Edward V. Loftus Jr., MD, AGAF, FACG, FACP


Recommendations Address ‘Public Health Concern’ of Hepatitis C in Pregnancy

In the Journals

Psoriasis, Inflammatory Diseases Increase Risk for Cirrhosis, Fatty Liver

Obesity Correlates With Discordance in Noninvasive Tests for Fibrosis

Whole Grain Diet Reduces Body Weight, Ineffective in Gut Microbiome

IBD Patients on Thiopurines, Anti-TNFs Show ‘Small but Significant’ Lymphoma Risk

Genetic Testing Underused in Colon Cancer, Especially Young Patients

Heavy Use of Prescription Opiates for IBD May Increase Mortality Rates

Meeting News

Biologics Safer, More Cost-effective Than Corticosteroids Long-term in IBD

Readmission Common After IPAA Surgery, Better Infection Control Needed

Colon Cancer Screening Should Begin at Age 45, Per New Study

‘Tight Control’ of Inflammatory Biomarkers Improves Outcomes in Crohn’s Disease

IPAA Surgery Safe in Older IBD Patients

Integrated Specialty Pharmacy Improves Access to IBD Drugs

Etrolizumab Shows Promise in Crohn’s Disease

Novel Blood Test Shows Promise for Parsing Celiac vs. Gluten Sensitivity

Trend Watch

Cost, Fear of Side Effects Key Barriers to HCV Treatment

Bristol-Myers Squibb, Intercept Continue Support of NASH Study

The IBD Medical Home: A Holistic Approach to Specialty Care